Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: September 2023

MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) New Subsidiary Maximizing Patented DehydraTECH(TM) in Various Markets

Posted on September 15, 2023 by MissionIR

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced the incorporation of a new wholly owned subsidiary under the name Lexaria Nutraceutical Corp. (“LEXX Nutra”). “LEXX Nutra will keep with Lexaria’s overall strategy of maximizing … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Looks Forward to Acclaim-3 Trial on Heels of Receipt of FDA FTD and ODD Designations

Posted on September 15, 2023 by MissionIR

Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes. The company recently announced that the United States Food and Drug Administration (“FDA”) had granted Orphan Drug Designation (“ODD”) to … Continue reading →

Posted in Genprex Inc. GNPX | Leave a comment

MissionIRNewsBreaks – Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Tapping Emerging Technologies to Address Unmet Mobile Money Needs

Posted on September 15, 2023 by MissionIR

Fintech Ecosystem Development Corp. (NASDAQ: FEXD) is working to develop a global financial technology ecosystem. “The company is keen on addressing unmet mobile money needs in developing and industrialized markets and making mobile transactions easier and more affordable. To turn … Continue reading →

Posted in Fintech Ecosystem Development Corp. FEXD | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Optimistic Berubicin May Provide Much-Needed Benefit for GBM Patients

Posted on September 15, 2023 by MissionIR

CNS Pharmaceuticals (NASDAQ: CNSP), a clinical-stage biotechnology company specializing in the development of novel treatments with a focus on brain cancer, glioblastoma (“GBM”) and neuro-oncology, recently presented updated safety results from its potentially pivotal clinical study on GBM treatment through … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

MissionIRNewsBreaks – Safety Shot (NASDAQ: SHOT) Rebrands with New Name, Ticker to Focus on New Business

Posted on September 15, 2023 by MissionIR

Safety Shot (NASDAQ: SHOT), formerly known as Jupiter Wellness, has announced that effective today it has changed its name to Safety Shot; its ticker will also change to SHOT. The changes come after the company acquired Safety Shot, the first … Continue reading →

Posted in Safety Shot Inc. SHOT | Leave a comment

MissionIRNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces $1.33M Registered Direct

Posted on September 15, 2023 by MissionIR

Scinai Immunotherapeutics (NASDAQ: SCNI) is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative inflammation and immunology (“I&I”) biological products primarily for the treatment of autoimmune and infectious diseases. The company today announced its entry into a definitive agreement … Continue reading →

Posted in Scinai Immunotherapeutics Ltd. SCNI | Leave a comment

MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Leveraging Technology, Innovative Services to Enhance US Safety

Posted on September 15, 2023 by MissionIR

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, is leveraging technology to improve public safety across the U.S. utilizing Amazon.com Inc.’s (NASDAQ: AMZN) Amazon Web Services (“AWS”). The announcement reads, “In Huntington … Continue reading →

Posted in Knightscope Inc. KSCP | Leave a comment

Eloro Resources Ltd. (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) Announce New Mining Updates; Confirm Timeline for NI-43101 Compliant MRE Report Publication

Posted on September 15, 2023 by MissionIR

Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mining company focused on developing its potential world-class Iska Iska silver-tin polymetallic property located in the Potosi Department in southern Bolivia, recently updated the market with updated assay results … Continue reading →

Posted in Eloro Resources Ltd. ELRRF | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) is On Track for IND Application with the FDA for its Planned U.S. Phase 1b Hypertension Clinical Trial

Posted on September 15, 2023 by MissionIR

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, remains on track for its upcoming submission of an Investigational New Drug (“IND”) application for its planned U.S. Phase 1b Hypertension Clinical Trial, dubbed HYPER-H23-1. The study, entitled “A … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) CEO Spotlighted in Recent ‘Bloomberg Technology’ Segment

Posted on September 15, 2023 by MissionIR

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services, was featured in the “Bloomberg Technology” daily news program earlier this week. During the insightful interview, D-Wave Quantum CEO Alan Baratz talked with host Ed Ludlow about … Continue reading →

Posted in D-Wave Quantum Inc. QBTS | Leave a comment